Key developments and materials

View Life Sciences by content type:

Latest Life Sciences News

Featured Life Sciences content

Practice notes
Rome II—application and interpretationThis Practice Note is for use when determining applicable law in respect of events giving rise to damage, where...
Read More >
19th May
Q&As
Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and...
Read More >
19th May
Practice notes
Brexit—exiting the EU under Article 50 [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note contains...
Read More >
Produced in partnership with Adam Cygan of University of Leicester 19th May
Practice notes
Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)CASE HUB See further,...
Read More >
19th May
Q&As
Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered...
Read More >
19th May
Practice notes
Rome Convention—introduction and interpretation [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.The UK is no longer...
Read More >
19th May
Precedents
Coronavirus (COVID-19): In addition to the below content on force majeure generally, see also: • Coronavirus (COVID-19)...
Read More >
19th May
Practice notes
Many companies and government bodies (such as HMRC) have been exposed to loss of confidential information and many other breaches of confidentiality...
Read More >
19th May
Practice notes
Introduction to retained EU lawThis Practice Note provides an introduction to retained EU law. It provides an overview of the key definitions and...
Read More >
Produced in partnership with Dr. Kieran Laird of Gowling WLG 19th May
Precedents
1 Counterparts—agreement 1.1 This agreement may be signed in any number of separate counterparts, each of which when...
Read More >
19th May
Practice notes
Model ADR clausesThis Practice Note considers model form alternative dispute resolution (ADR) clauses provided by a number of service providers,...
Read More >
19th May
Precedents
Option 1—contract signed on behalf of a company, where the authorised signatory is an individual Signed by [insert name of...
Read More >
19th May
Practice notes
Requirements of the company sealThis Practice Note provides practical guidance regarding the requirements of the company seal. Where a company has a...
Read More >
19th May
Practice notes
Brexit implementation period—enforcement [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers...
Read More >
19th May
Practice notes
SubcontractingThis Practice Note examines the following legal and practical matters in relation to entering into a subcontract or when granting...
Read More >
19th May
Practice notes
ScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that are placed on the...
Read More >
Produced in partnership with Taylor Wessing LLP 19th May

Most recent Key developments and materials content

Precedents
Interactions between the pharmaceutical industry and healthcare professionals—training materialsIP COMPLETION DAY: 11pm (GMT) on 31 December 2020...
Read More >
25th Jul
Precedents
Technology transfer agreements and competition law—training materialsIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit...
Read More >
25th Jul
Practice notes
Design rights before and after Brexit—comparison tableDesign rights before and after BrexitThe purpose of this Practice Note is to summarise, at a...
Read More >
25th Jul
Practice notes
Life sciences tracker [Archived]ARCHIVED: This Practice Note has been archived and it is not maintained. It contains closed legislative proposals,...
Read More >
25th Jul
Practice notes
Life sciences tracker—UKThis Practice Note is intended to be used to track the progress of UK legislative proposals, relevant cases and current...
Read More >
25th Jul
Practice notes
Life sciences—Brexit tracker [Archived]ARCHIVED: This Practice Note has been archived and it is not maintained. It contains previous key developments...
Read More >
25th Jul
Practice notes
Brexit—implications for data protectionThis Practice Note discusses the impact of Brexit on the general processing of personal data under the General...
Read More >
25th Jul
Practice notes
What does IP completion day mean for Life Sciences?11 pm (GMT) on 31 December 2020 marked the end of the implementation period put in place to enable...
Read More >
25th Jul
Practice notes
Patents trackerThis Practice Note is intended to be used to track the progress of judgments, legislative proposals and consultations related to...
Read More >
25th Jul
Practice notes
Post-Brexit transition period—the regulation of medicinal productsThis Practice Note considers the potential impact of the end of the transition...
Read More >
25th Jul
Practice notes
Medicines and Medical Devices Act 2021This Practice Note provides an overview of the Medicines and Medical Devices Act 2021 (MMDA 2021) which, in...
Read More >
25th Jul
Practice notes
Coronavirus (COVID-19)—regulatory implications for the UK and European life sciences industryCoronavirus (COVID-19) presents an unprecedented...
Read More >
Produced in partnership with Maria Isabel Manley of Sidley Austin, Zina Chatzidimitriadou of Sidley Austin and Sidley Austin 25th Jul
Practice notes
Life sciences—new starter guideThis new starter guide provides an introduction to the life sciences practice area, the legislative and regulatory...
Read More >
25th Jul
Practice notes
Coronavirus (COVID-19) and intellectual property rightsThis Practice Note discusses some of the key considerations and implications for IP...
Read More >
25th Jul
Practice notes
Patents tracker [Archived]ARCHIVED: This Practice Note has been archived and is no longer maintained. It contains closed legislative proposals,...
Read More >
25th Jul
Practice notes
Trade mark rights before and after Brexit—comparison tableTrade mark rights before and after BrexitThe purpose of this Practice Note is to summarise,...
Read More >
25th Jul
Practice notes
What does IP completion day mean for medicinal products?11 pm (GMT) on 31 December 2020 marked the end of the implementation period put in place to...
Read More >
25th Jul
Practice notes
What does IP completion day mean for clinical trials?11 pm (GMT) on 31 December 2020 marked the end of the implementation period put in place to...
Read More >
25th Jul
Practice notes
Brexit—implications of the Withdrawal Agreement for the life sciences sector [Archived]ARCHIVED: This Practice Note has been archived and is not...
Read More >
25th Jul
Precedents
Confidentiality—training materialsThese training materials contain template PowerPoint slides and associated notes for use by a trainer when outlining...
Read More >
25th Jul

Popular documents